1,721,372 research outputs found
Classification of patients with antiphospholipid syndrome into risk categories: An evolving process
No full text
Long-term warfarin use to prevent both stroke and dementia in subjects with atrial fibrillation?
No full text
Anti-beta2-glycoprotein I antibody testing in the laboratory diagnosis of antiphospholipid syndrome.
No full textPathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: comment
No full textA contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome
No full textAntiphospholipid antibody detection assays: The real life in 2007. How the assays should be used? Lupus anticoagulant
No full textOral anticoagulant therapy in patients with atrial fibrillation
No full textIn the absence of contraindications, patients with atrial fibrillation and at least one major risk factor for stroke should receive long-term oral anticoagulant treatment to prevent atrial thrombus formation. Because age of more than 75 years is a major risk factor for stroke, but is also a risk factor for major bleeding, the decision to treat elderly patients with anticoagulants should be made on an individual basis
- …
